Spyros Papapetropoulos

2021

In 2021, Spyros Papapetropoulos earned a total compensation of $1.1M as Chief Medical Officer at Vigil Neuroscience, a 91% increase compared to previous year.

Compensation breakdown

Bonus$50,000
Non-Equity Incentive Plan$154,805
Option Awards$533,148
Salary$396,935
Total$1,134,888

Papapetropoulos received $533.1K in option awards, accounting for 47% of the total pay in 2021.

Papapetropoulos also received $50K in bonus, $154.8K in non-equity incentive plan and $396.9K in salary.

Rankings

In 2021, Spyros Papapetropoulos' compensation ranked 8,353rd out of 12,406 executives tracked by ExecPay. In other words, Papapetropoulos earned more than 32.7% of executives.

ClassificationRankingPercentile
All
8,353
out of 12,406
33rd
Division
Manufacturing
3,695
out of 5,492
33rd
Major group
Chemicals And Allied Products
1,644
out of 2,368
31st
Industry group
Drugs
1,462
out of 2,089
30th
Industry
Biological Products, Except Diagnostic Substances
325
out of 452
28th
Source: SEC filing on April 28, 2022.

Papapetropoulos' colleagues

We found two more compensation records of executives who worked with Spyros Papapetropoulos at Vigil Neuroscience in 2021.

2021

Ivana Magovčević-Liebisch

Vigil Neuroscience

Chief Executive Officer

2021

Jennifer Ziolkowski

Vigil Neuroscience

Chief Financial Officer

News

You may also like